This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          July 14, 2015

Home  |   About ASHI  |   Education  |   Publications  |   Meetings  |   Careers  |   News  |   Lab Center


Proficiency Testing
Click here to place your 2015 Proficiency Testing order or to view your previous Performance and Summary reports.

Renew Your Membership Now!
It's not too late to renew your ASHI membership. If you haven't received your second dues renewal notice, please contact the ASHI central office at info@ashi-hla.org.

ASHI U
Access to educational information is free to ASHI members. CECs are awarded through an online testing process and are free to ASHI members.
 


ASSOCIATION NEWS


2015 Award Winners
The American Society for Histocompatibility and Immunogenetics announces the 2015 Award Winners:

Rose Payne Award
Frans Claas, Ph.D.
Leiden University Medical Center

Distinguished Scientist Award
Marcelo Fernandez-Vina, Ph.D., D(ABHI)
Stanford University School of Medicine

Paul I. Terasaki Clinical Science Award
Dolly Tyan, Ph.D., D(ABHI)
Stanford University School of Medicine

Distinguished Service Award
Marilyn Pollack, Ph.D., D(ABHI)
Children's Hospital, Oakland

Outstanding Technologist Award
Dawn Wagenknecht, MS, CHS
Franciscan St. Francis Health

Rising Star Award (click here to read Ms. Manna's essay)
Deanna Manna, BS, BA
Alberta Health Services

ASHI Scholars
Chrysanthi Tsamadou, M.D.
Institute of Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service - International Scholar Award

Peter M. Clark, Ph.D.
The Children's Hospital of Philadelphia

Yi-Ping Jin, M.D.
University of California Los Angeles

Andrea Patterson, B.Sc
University of Oklahoma Health Sciences Center

Please join us in congratulating this year's winners! Visit our website to learn more about the criteria for each of the awards.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


In Memoriam
Dear ASHI Colleagues, We are very saddened to inform you that Dr. F. Carl Grumet, the former Director of the Stanford HLA lab and current ASHI member passed away on Saturday, July 11, 2015.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MISSED AN ISSUE OF ASHI INSIGHTS?
Click here
to visit the ASHI Insights archive page.


ASHI 41st Annual Meeting registration is open!

The ASHI 41st Annual Meeting will take place at the Savannah International Trade & Convention Center September 28 – October 2, 2015 in Savannah, Georgia.

Advance registration is strongly recommended as space is limited. Registration forms, including complete payment, must be received by August 19, 2015 to guarantee attendance. Additionally, advance registration ensures timely processing of your registration and helps avoid on-site delays. Register now!

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Your vote matters!
2015 board election and proposed bylaws amendments ballot

Ballots were mailed out to full-doctoral and non-doctoral ASHI members.

IMPORTANT NOTICE

The following guidelines must be followed in order for these ballots to be valid.
  1. Do not write your name on this ballot.
  2. Print and sign your name on the inside flap of the pre-addressed return envelope. If the envelope is received without this information, the ballot will be invalid.
  3. Place your completed ballot in the pre-addressed return envelope, seal and mail.
  4. To be counted, your ballot must be postmarked by Aug. 3, 2015. Ballots postmarked after that date will be invalid.
  5. Only the original ballot will be accepted for tabulation of votes. Ballots that have been copied or altered in any way will not be counted.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


INDUSTRY NEWS


Quantitative and functional analysis of CD69+ NKG2D+ T regulatory cells in healthy subjects
Human Immunology
T regulatory (Treg) cells have a key role in immune homeostasis and the pathogenesis of chronic inflammatory and autoimmune diseases. CD69 is an early leukocyte activation molecule that under steady state conditions is detected in a small proportion of lymphocytes in peripheral blood and lymphoid tissues. Although it has been reported that a subset of CD69+ T cells behaves as Treg lymphocytes, the possible relationship between CD69+ Treg cells and CD4+ NKG2D+ T lymphocytes, which also exert immunosuppressive activity, has not been explored.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


NIH to fund genomics studies linking HLA and KIR regions with disease
GenomeWeb
The National Institute of Health will award up to $3.4 million next year to fund genomics research programs and projects aimed at better understanding how two complex human genomic regions are involved in a range of immune system diseases. The grants will support research programs focused on the HLA (human leukocyte antigen) and the KIR (natural killer cell immunoglobin-like receptor) genomic regions, which are involved in human susceptibility and resistance to immune-related diseases.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival
American Journal of Transplantation
Predicting long-term outcomes in renal transplant recipients is essential to optimize medical therapy and determine the frequency of posttransplant histologic and serologic monitoring. Nonadherence and human leukocyte antigen mismatch are risk factors that have been associated with poor long-term outcomes and may help individualize care. In the present study, class II HLA mismatches were determined at the HLA epitope level in 195 renal transplant recipients in whom medication adherence was prospectively measured using electronic monitors in medication vial caps. Recipients were grouped by medication adherence and high (≥10 HLA-DR, ≥17 HLA-DQ) or low epitope-mismatch load.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Response to 'Influence of Age and HLA Alleles on the CMV-Specific Cell-Mediated Immunity Among CMV-Seropositive Kidney Transplant Candidates'
American Journal of Transplantation
We would like to thank Fernández-Ruiz et al for their interest in our manuscript and welcome the opportunity to address their comments on the factors influencing CMV-specific T cell response in transplant candidates. Whereas we show an association between HLA-A1 and/or HLA-A2 alleles and age older than 50 with CMV-specific CD8+ T cell response, their results did not show this association. Although the studies are apparently contradictory, they have considerable methodological differences which impact the results and their interpretation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASHI Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671  
Contribute news


Learn how to add us to your safe sender list so our emails get to your inbox.

This edition of ASHI Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 30, 2015
June 16, 2015
June 2, 2015





7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063